tiprankstipranks
Trending News
More News >
Nutrien Ltd (TSE:NTR)
TSX:NTR
Advertisement

Nutrien (NTR) AI Stock Analysis

Compare
767 Followers

Top Page

TSE:NTR

Nutrien

(TSX:NTR)

Rating:69Neutral
Price Target:
C$86.00
▲(6.09% Upside)
Nutrien's overall stock score is driven by strong earnings call performance and improving cash flows, despite challenges in profitability and technical indicators. The company's strategic cost savings and increased shareholder returns are positive, but valuation concerns and market pressures weigh on the score.
Positive Factors
Crop Outlook
US corn planting is largely complete, and crop conditions are progressing well, indicating a strong 2025 crop outlook.
Future Performance
Despite a weak start to the year, Nutrien maintained its full-year guidance, which suggests confidence in future performance.
Market Dynamics
The potash market dynamics are positive, with strong demand and supply constraints tightening the market.
Negative Factors
Earnings Growth
A lack of earnings growth and limited prospects for sustained higher fertilizer prices will weigh on sentiment.
Financial Performance
Nutrien reported weak first-quarter results, with revenue weaker across all segments and EBITDA below forecast across all segments except Potash.
Share Price
The company is downgraded to Market Perform due to significant share price gains, which limits further upside potential.

Nutrien (NTR) vs. iShares MSCI Canada ETF (EWC)

Nutrien Business Overview & Revenue Model

Company DescriptionNutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia. In addition, it provides services directly to growers through a network of farm centers in North America, South America, and Australia. The company was founded in 2017 and is headquartered in Saskatoon, Canada.
How the Company Makes MoneyNutrien generates its revenue primarily through the sale of fertilizers, which are essential for crop production. The company's key revenue streams include the production and sale of potash, nitrogen, and phosphate fertilizers. Nutrien also earns income from agricultural services, which encompass seed sales, crop protection products, and agronomic advice. The company's revenue model is supported by its extensive retail network, allowing it to reach farmers directly. Additionally, Nutrien benefits from significant partnerships with agricultural producers and retailers, which enhance its distribution capabilities and market presence. Factors such as global crop demand, commodity prices, and agricultural trends significantly influence Nutrien's earnings.

Nutrien Earnings Call Summary

Earnings Call Date:Aug 06, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 05, 2025
Earnings Call Sentiment Positive
The earnings call highlights strong operational performance, record sales in potash, and significant cost savings, contributing to increased shareholder returns. However, challenges in controllable cash costs, weather impacts on Retail, and pressures on farmer margins present potential risks.
Q2-2025 Updates
Positive Updates
Record Potash Sales Volumes
Nutrien achieved record potash sales volumes in the first half of 2025, contributing to increased earnings and cash from operations.
Nitrogen Segment Performance
Nitrogen operations achieved a 98% ammonia utilization rate, with completed debottlenecking efforts adding 150,000 tonnes of annual production capacity.
Cost Savings and Reduced Capital Expenditures
Nutrien is ahead of schedule on its $200 million cost savings target and capital expenditures were 18% below the previous year.
Increased Shareholder Returns
The company allocated $786 million to dividends and share repurchases in the first half, a 49% increase from the previous year.
Strong Retail Segment Performance
The Retail segment delivered adjusted EBITDA of $1.15 billion in Q2, up 2% from the prior year, with strong crop input demand in the U.S. Corn Belt.
Negative Updates
Higher Controllable Cash Costs in Potash
First half controllable cash cost of product manufactured was higher than the previous year due to lower planned potash production and increased turnaround costs.
Weather Challenges Affecting Retail
Unfavorable weather conditions in Australia and the Southern U.S. impacted seed sales and crop mix, reducing potential revenue.
Phosphate Segment Challenges
Phosphate adjusted EBITDA was impacted by lower sales volumes and higher sulfur input costs, despite higher net selling prices.
Pressure on Farmer Margins
Lower ag commodity prices and grower margins posed potential risks to future fertilizer demand despite current strong engagement.
Company Guidance
In the 2025 second quarter earnings call, Nutrien provided several key metrics and guidance updates. The company reported record potash sales volumes and nitrogen operating rates in the first half of 2025, with potash sales volumes guidance for the full year raised to 13.9 to 14.5 million tonnes. Nitrogen operations achieved a 98% ammonia utilization rate, and the company completed brownfield debottlenecking at Redwater and Geismar plants, adding 150,000 tonnes of annual production capacity. Nutrien also reduced capital expenditures by 18% compared to the prior year and increased returns to shareholders through $786 million in dividends and share repurchases, a 49% increase from the previous year. The company is ahead of schedule on its $200 million cost savings target, expecting to achieve it in 2025. Nutrien's adjusted EBITDA for the second quarter was $2.5 billion, an 11% increase from the previous year, with cash provided by operating activities rising by 40%. Looking forward, the company anticipates stable demand in Brazil and has a positive outlook for the potash market, expecting global shipments of 73 to 75 million tonnes for 2025.

Nutrien Financial Statement Overview

Summary
Nutrien's financial health shows stable profitability margins and a strong equity position, but declining revenue and free cash flow growth are concerns. The company needs strategic improvements to enhance overall financial performance.
Income Statement
70
Positive
The company's income statement shows a mixed performance. The gross profit margin for TTM (Trailing-Twelve-Months) is 28.47%, which is decent, but the net profit margin is low at 2.05%, indicating challenges in converting revenue into profit. Revenue growth has been negative recently, declining by 8.91% from 2024 to 2025, which is concerning. EBIT and EBITDA margins for TTM are moderate at 10.51% and 18.47%, respectively. Overall, the income statement reflects stable margins but with a downward revenue trend.
Balance Sheet
75
Positive
The balance sheet presents a solid equity position with an equity ratio of 45.32% for TTM, indicating a strong equity cushion. The debt-to-equity ratio stands at 0.61, suggesting moderate leverage. Return on equity (ROE) is low at 2.19%, showing limited profitability relative to equity. Despite some leverage, the company's balance sheet is stable, with a good proportion of assets financed by equity.
Cash Flow
65
Positive
Cash flow metrics indicate some areas of concern. Free cash flow growth has declined significantly by 37.79% from 2024 to TTM. The operating cash flow to net income ratio is robust at 5.58, suggesting efficient cash generation relative to earnings. However, the free cash flow to net income ratio of 1.63 for TTM highlights potential issues in maintaining free cash flow levels. Overall, cash flow performance shows strong operational cash flow but declining free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue25.96B25.97B29.06B37.88B27.71B20.91B
Gross Profit7.58B7.53B8.47B15.42B9.41B5.24B
EBITDA4.99B4.21B4.88B12.07B6.58B2.89B
Net Income1.36B674.00M1.26B7.66B3.15B459.00M
Balance Sheet
Total Assets53.26B51.84B52.75B54.59B49.95B47.19B
Cash, Cash Equivalents and Short-Term Investments1.39B853.00M941.00M901.00M499.00M1.45B
Total Debt13.64B12.81B12.57B11.93B10.85B11.36B
Total Liabilities28.14B27.40B27.55B28.72B26.25B24.83B
Stockholders Equity25.09B24.41B25.16B25.82B23.65B22.36B
Cash Flow
Free Cash Flow1.71B1.38B2.47B5.67B2.10B1.77B
Operating Cash Flow3.67B3.54B5.07B8.11B3.89B3.32B
Investing Cash Flow-1.76B-2.13B-2.96B-2.90B-1.81B-1.20B
Financing Cash Flow-1.52B-1.45B-2.06B-4.73B-3.00B-1.34B

Nutrien Technical Analysis

Technical Analysis Sentiment
Positive
Last Price81.06
Price Trends
50DMA
81.10
Negative
100DMA
79.02
Positive
200DMA
73.99
Positive
Market Momentum
MACD
-0.26
Negative
RSI
55.49
Neutral
STOCH
76.38
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NTR, the sentiment is Positive. The current price of 81.06 is above the 20-day moving average (MA) of 79.58, below the 50-day MA of 81.10, and above the 200-day MA of 73.99, indicating a neutral trend. The MACD of -0.26 indicates Negative momentum. The RSI at 55.49 is Neutral, neither overbought nor oversold. The STOCH value of 76.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:NTR.

Nutrien Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$39.52B20.885.43%3.75%-0.74%78.08%
61
Neutral
$10.31B6.160.76%2.94%3.30%-36.34%
43
Neutral
C$5.86M-15.71%51.79%
43
Neutral
C$24.75M-36.07%-36.74%15.76%
$414.67M3.7930.90%
$9.75M-32.32%
$28.37M-201.16%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:NTR
Nutrien
80.24
17.91
28.74%
TSE:KRN
Karnalyte Resources
0.09
-0.04
-30.77%
TSE:NPK
Verde Agritech
0.45
-0.21
-31.82%
ITFS
Itafos
2.14
0.99
86.09%
VVIVF
EarthRenew
0.06
0.02
50.00%
MGROF
MustGrow Biologics
0.55
-0.11
-16.67%

Nutrien Corporate Events

Dividends
Nutrien Declares Quarterly Dividend of US$0.545 per Share
Positive
Aug 6, 2025

Nutrien Ltd. has announced a quarterly dividend of US$0.545 per share, payable on October 17, 2025, to shareholders of record as of September 29, 2025. The dividend will be paid in Canadian dollars to Canadian residents and in US dollars to non-residents, with the option for registered shareholders to change the currency of their payments. This announcement reflects Nutrien’s ongoing commitment to providing value to its shareholders and maintaining its strong position in the agricultural industry.

The most recent analyst rating on (TSE:NTR) stock is a Buy with a C$75.00 price target. To see the full list of analyst forecasts on Nutrien stock, see the TSE:NTR Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Nutrien Reports Strong Q2 2025 Results Amid Favorable Fertilizer Market
Positive
Aug 6, 2025

Nutrien Ltd. reported strong financial results for the second quarter of 2025, with net earnings of $1.2 billion and adjusted EBITDA of $2.5 billion. The company achieved record potash sales volumes and increased nitrogen operating rates, supported by robust global demand and supply disruptions in the fertilizer market. Nutrien raised its full-year potash sales volume guidance while maintaining other operational priorities, reflecting its strategic focus on optimizing capital expenditures and returning cash to shareholders.

The most recent analyst rating on (TSE:NTR) stock is a Buy with a C$75.00 price target. To see the full list of analyst forecasts on Nutrien stock, see the TSE:NTR Stock Forecast page.

Stock BuybackDividendsBusiness Operations and StrategyFinancial Disclosures
Nutrien Reports Strong Q2 2025 Results Amid Fertilizer Market Demand
Positive
Aug 6, 2025

Nutrien Ltd. reported strong financial results for the second quarter of 2025, with net earnings of $1.2 billion and an adjusted EBITDA of $2.5 billion. The company achieved record sales volumes in potash and increased nitrogen operating rates, driven by robust global demand and supply disruptions in the fertilizer market. Nutrien is raising its full-year potash sales volume guidance while maintaining its capital allocation priorities. The company returned $0.8 billion to shareholders through dividends and share repurchases, highlighting its commitment to shareholder value.

The most recent analyst rating on (TSE:NTR) stock is a Buy with a C$75.00 price target. To see the full list of analyst forecasts on Nutrien stock, see the TSE:NTR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 21, 2025